Section Arrow
Quote
BDMD.NASDAQ
- Baird Medical Investment Holdings Ltd
Quotes are at least 15-min delayed:2025/08/26 07:43 EDT
Pre Market
Last
 2.36
-0.03 (-1.26%)
Bid
2.25
Ask
2.48
High 2.36 
Low 2.36 
Volume 10 
Regular Hours
Last
 2.39
+0.09 (+3.91%)
Day High 
2.4448 
Prev. Close
2.3 
1-M High
3.7499 
Volume 
156.19K 
Bid
2.25
Ask
2.48
Day Low
2.2004 
Open
2.33 
1-M Low
1.8 
Market Cap 
85.14M 
Currency USD 
P/E 4.69 
%Yield -- 
10-SMA 2.27 
20-SMA 2.16 
50-SMA 3.34 
52-W High 13.52 
52-W Low 1.05 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.49/--
Enterprise Value
88.72M
Balance Sheet
Book Value Per Share
1.07
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
37.04M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc0.4899-0.0101-2.02%-- 
Pre Market 0.7728 +0.2829 +57.75%
DXCMDexCom75.96-6.3-7.66%57.93PE
Pre Market 76 +0.04 +0.05%
MDTMedtronic plc92.04-0.67-0.72%25.68PE
Pre Market 92.05 +0.01 +0.01%
BFLYButterfly Network1.55+0.03+1.97%-- 
Pre Market 1.64 +0.09 +5.81%
ABTAbbott Laboratories131.87-0.72-0.54%16.64PE
Pre Market 131.84 -0.03 -0.02%
Quotes are at least 15-min delayed：2025/08/26 07:43 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.